215 related articles for article (PubMed ID: 19662737)
21. Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?
Behrens GM; Stoll M; Schmidt RE
Drug Saf; 2000 Jul; 23(1):57-76. PubMed ID: 10915032
[TBL] [Abstract][Full Text] [Related]
22. Metabolic and skeletal complications of HIV infection: the price of success.
Morse CG; Kovacs JA
JAMA; 2006 Aug; 296(7):844-54. PubMed ID: 16905789
[TBL] [Abstract][Full Text] [Related]
23. Lipodystrophy and metabolic disorders as complication of antiretroviral therapy of HIV infection.
Holstein A; Plaschke A; Egberts EH
Exp Clin Endocrinol Diabetes; 2001; 109(8):389-92. PubMed ID: 11748485
[TBL] [Abstract][Full Text] [Related]
24. [Endocrine-metabolic changes in patients infected with the human immunodeficiency virus].
Alvarez Hernández J
Rev Clin Esp; 1994 May; 194(5):352-60. PubMed ID: 8059033
[No Abstract] [Full Text] [Related]
25. HIV-associated lipodystrophy syndrome.
Qaqish RB; Fisher E; Rublein J; Wohl DA
Pharmacotherapy; 2000 Jan; 20(1):13-22. PubMed ID: 10641972
[TBL] [Abstract][Full Text] [Related]
26. [Endocrine involvement in HIV infections].
Luckhaus J
Zentralbl Gynakol; 1999; 121(1):30-2. PubMed ID: 10091311
[TBL] [Abstract][Full Text] [Related]
27. HIV infection, highly active antiretroviral therapy and the cardiovascular system.
Barbaro G
Cardiovasc Res; 2003 Oct; 60(1):87-95. PubMed ID: 14522410
[TBL] [Abstract][Full Text] [Related]
28. Aetiology and pathogenesis of hormonal and metabolic disorders in HIV infection.
Grinspoon SK; Donovan DS; Bilezikian JP
Baillieres Clin Endocrinol Metab; 1994 Oct; 8(4):735-55. PubMed ID: 7811218
[TBL] [Abstract][Full Text] [Related]
29. The Prevalence and Pattern of Thyroid Dysfunction in HAART-Naïve HIV Patients in Enugu, Nigeria: A Cross-Sectional Comparative Study.
Ugwueze CV; Young EE; Unachukwu CN; Onyenekwe BM; Nwatu CB; Okafor CI; Ezeude CM; Ezeokpo BC
West Afr J Med; 2021 Dec; 38(12):1200-1205. PubMed ID: 35037450
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
31. Interventions for metabolic and endocrine complications of human immunodeficiency virus/acquired immune deficiency syndrome and illicit drug use. Proceedings of a workshop. 26-27 November 2001.
Clin Infect Dis; 2003; 37 Suppl 2():S37-153. PubMed ID: 14569966
[No Abstract] [Full Text] [Related]
32. [Endocrinological aspects of acquired immunodeficiency syndrome (AIDS)].
Nduwayo L; Nsabiyumva F; Osorio Salazar C; Lecomte P; Guilmot JL; Renard JP
Med Trop (Mars); 1992; 52(2):139-43. PubMed ID: 1406212
[TBL] [Abstract][Full Text] [Related]
33. Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.
Barbaro G
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):337-43. PubMed ID: 16101566
[TBL] [Abstract][Full Text] [Related]
34. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus.
Grinspoon SK
Am J Med; 2005 Apr; 118 Suppl 2():23S-28S. PubMed ID: 15903292
[TBL] [Abstract][Full Text] [Related]
35. Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.
Fantoni M; Del Borgo C; Autore C; Barbaro G
Ital Heart J; 2002 May; 3(5):294-9. PubMed ID: 12066561
[TBL] [Abstract][Full Text] [Related]
36. Endocrine complications of AIDS and drug addiction.
Brown LS; Singer F; Killian P
Endocrinol Metab Clin North Am; 1991 Sep; 20(3):655-73. PubMed ID: 1935923
[TBL] [Abstract][Full Text] [Related]
37. The effects of HIV-1 infection on endocrine organs.
Brown TT
Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):403-13. PubMed ID: 21663835
[TBL] [Abstract][Full Text] [Related]
38. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.
Schambelan M; Benson CA; Carr A; Currier JS; Dubé MP; Gerber JG; Grinspoon SK; Grunfeld C; Kotler DP; Mulligan K; Powderly WG; Saag MS;
J Acquir Immune Defic Syndr; 2002 Nov; 31(3):257-75. PubMed ID: 12439201
[TBL] [Abstract][Full Text] [Related]
39. [Lipid disorders in patients with HIV-induced diseases].
Chanu B; Valensi P
Presse Med; 2005 Sep; 34(15):1087-94. PubMed ID: 16334888
[TBL] [Abstract][Full Text] [Related]
40. Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.
Mirani G; Williams PL; Chernoff M; Abzug MJ; Levin MJ; Seage GR; Oleske JM; Purswani MU; Hazra R; Traite S; Zimmer B; Van Dyke RB;
Clin Infect Dis; 2015 Dec; 61(12):1850-61. PubMed ID: 26270680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
